The home CPAP device maker Resmed is launching a small, disposable wearable to help diagnose cases of obstructive sleep apnea ...

A new Resmed-supported study showing sleep apnea patients on CPAP therapy live longer will further fuel a “once-in-a-generation opportunity” to increase awareness, says Carlos Nunez, ...

At Pune’s Surya Mother and Child Superspeciality Hospital, Priyanka and Akshay Pate barely had the time to mourn the death of ...

Early CPAP treatment for individuals with OSA may help reduce the onset of Parkinson disease and other neurodegenerative diseases.

In the search for effective treatments against sleep apnoea, a new milestone has just been reached in England. The innovation ...

Let's see which of these two names could be best buys. The post Should I buy Fisher & Paykel or ResMed shares? appeared first ...

NightOwl, an FDA-cleared home sleep apnea test (HSAT) offers a simplified, accurate, efficient way to diagnose obstructive sleep apnea (OSA). It adds another offering to Resmed’s portfolio, which is ...

Three experts explain how obstructive sleep apnea, an often-ignored cardiovascular risk factor, may affect your heart and treatment options.

NightOwl is now widely available across the United States. Individuals interested in NightOwl should speak with their healthcare provider for more information. To learn more, visit: https://www.resmed ...

Dr. David Blaine and Dr. Justin Douglas, otolaryngologists at the Beckley ARH Hospital Ear, Nose and Throat Clinic, recently ...

Among patients with obstructive sleep apnea using CPAP, pitolisant given at 20 mg and 40 mg reduces excessive daytime sleepiness.